Commentary|Podcasts|January 20, 2025
Reaching Diverse Patient Populations With Personalized Treatment Methods
Author(s)Andy Studna, Senior Editor
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses:
- Industry’s greatest challenges in reaching diverse patient populations
- Personalized treatment methods
- Recruitment strategies
- and more!
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
4
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
